Is low blood pressure the cause of an adverse outcome or an effect of the extended cardiovascular disease in the prognostic value of the blood pressure in ONTARGET trial?
- PMID: 19893435
- DOI: 10.1097/HJH.0b013e328330ee42
Is low blood pressure the cause of an adverse outcome or an effect of the extended cardiovascular disease in the prognostic value of the blood pressure in ONTARGET trial?
Comment on
-
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.J Hypertens. 2009 Jul;27(7):1360-9. doi: 10.1097/HJH.0b013e32832d7370. J Hypertens. 2009. PMID: 19506526 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
